DNA Technology participated in the 41^st Nordic society for Hematology meeting in Uppsala, Sweden. During the meeting there was good dialogue with both haematologists as well as geneticist and other laboratory people. It is, however obvious that the prevailing diagnostic strategies in Scandinavia are not including thorough high resolution genetic analysis of many patients who could benefit from such initial diagnosis. The continous dialogue between laboratory and clinics is essential.